XML 66 R50.htm IDEA: XBRL DOCUMENT v3.25.0.1
Equity-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Option Activity
The table below presents the activity of stock options under the Plan:
Number of Options
Weighted-Average Grant Date Fair Value per ShareWeighted-Average Exercise Price per ShareWeighted-Average Remaining Contractual Term (Years)
Outstanding as of December 31, 2022
2,153,591 $2.70 $7.22 8.60
Expired(13,001)3.28 9.86 
Forfeited(37,999)2.81 7.74 
Outstanding as of December 31, 20232,102,591 $2.69 $7.20 7.42
Exercised(188,751)1.87 8.24 
Expired(105,568)1.77 9.99 
Forfeited(65,330)2.43 5.98 
Outstanding as of December 31, 2024
1,742,942 $2.64 $6.96 7.04
Schedule of Monte-Carlo Simulation Following Assumptions
The fair value of PSUs granted under the Plan was estimated on the grant date using the Monte Carlo simulation model with the following assumptions:
2024 Grants
2023 Grants
Valuation date stock price
$7.45 $2.63 
Remaining term of performance period
2.47 years2.49 years
Expected volatility71.50 %81.00 %
Risk-free rate of return4.34 %4.70 %
Expected annual dividend yield— %— %
Schedule of Restricted Stock Units Activity
The table below presents the activity of performance-based restricted stock units under the Plan:
Number of PSUs
Weighted-Average Grant Date Fair Value per ShareWeighted-Average Remaining Contractual Term (in Years)Aggregate Intrinsic Value
Outstanding as of December 31, 2023706,097 $3.15 2.0$2,012 
Granted821,365 12.66 
Vested
— — 
Forfeited(67,500)3.50 
Outstanding as of December 31, 2024
1,459,962 $8.48 1.6$24,031 
The table below presents the activity of restricted stock units under the Plan:
Number of RSUs
Weighted-Average Grant Date Fair Value per ShareWeighted-Average Remaining Contractual Term (in Years)Aggregate Intrinsic Value
Unvested as of December 31, 20222,282,778 $6.30 1.3$4,520 
Granted1,846,112 2.62 
Vested(979,810)6.44 
Forfeited(297,865)6.33 
Unvested as of December 31, 20232,851,215 $3.89 1.2$8,126 
Granted1,296,910 6.89 
Vested(1,367,827)4.76 
Forfeited(338,327)4.38 
Unvested as of December 31, 2024
2,441,971 $4.93 1.1$40,195 
Schedule of Stock Compensation Expense
The table below presents the equity-based compensation expense recorded for the following periods:
Year Ended
December 31, 2024December 31, 2023
Cost of sales
ESPP
$237 $— 
Stock options
15 117 
Restricted stock units
1,903 2,540 
Performance-based restricted stock units
43 13 
Total cost of sales$2,198 $2,670 
Selling, general and administrative expenses
ESPP
$142 $— 
Stock options
1,155 1,578 
Restricted stock units
5,117 3,982 
Performance-based restricted stock units
2,714 428 
Total selling, general and administrative expenses$9,128 $5,988 
Total equity-based compensation expense$11,326 $8,658